What is the global market size of Antimicrobial Susceptibility Testing?

Global Antimicrobial Susceptibility Testing Market size was valued at USD 3.42 billion in 2021 and is poised to grow from USD 3.60 billion in 2022 to USD 5.40 billion by 2030, at a CAGR of 5.2% during the forecast period (2023-2030).

What is the key driver of the Global Antimicrobial Susceptibility Testing Market?

The rise in antimicrobial resistance is a significant driver for the AST market. The emergence of drug-resistant pathogens poses a severe threat to public health globally. For instance, the increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections has created a dire need for accurate AST to guide clinicians in selecting appropriate antibiotics for treatment.

What is the key market trend for the Global Antimicrobial Susceptibility Testing Market?

Integration of artificial intelligence (AI) and machine learning: The integration of AI and machine learning algorithms in AST data analysis is a growing trend. These technologies can assist in the interpretation of complex datasets and improve the accuracy and speed of AST results interpretation. For example, the AI-powered platform DeepAMR uses machine learning to predict bacterial susceptibility to antibiotics based on genomic data.

Which region accounted for the largest share in the Global Antimicrobial Susceptibility Testing Market?

North America dominated the global AST market, accounting for a substantial market share. The region's dominance can be attributed to several factors, including advanced healthcare infrastructure, well-established laboratory networks, and a strong focus on research and development activities. North America is home to prominent market players, such as bioMérieux, Thermo Fisher Scientific, and BD, which contribute to the region's market leadership. Additionally, the high prevalence of antimicrobial resistance and the proactive measures taken by healthcare organizations to address the issue drive the adoption of AST technologies in the region. With supportive government initiatives, strong investments in healthcare, and a growing emphasis on patient safety, North America holds a significant market share in the global AST market.

Antimicrobial Susceptibility Testing Market Companies

Antimicrobial Susceptibility Testing Market Competitive Landscape

Global Antimicrobial Susceptibility Testing (AST) Market features a competitive landscape with several prominent players vying for market share. Key companies operating in the market are actively engaged in research and development activities to introduce advanced AST systems and technologies. Strategic collaborations, partnerships, and acquisitions are common strategies employed by these players to expand their product portfolio and strengthen their market presence. The market is characterized by intense competition, with a focus on innovation, cost-effectiveness, and accuracy of AST solutions. The presence of established players with strong distribution networks and brand recognition presents barriers to entry for new entrants.

Antimicrobial Susceptibility Testing Market Top Player’s Company Profile

Thermo Fisher Scientific Inc. (US)

Bio-Rad Laboratories, Inc. (US)

Danaher Corporation (US)

Becton, Dickinson and Company (US)

bioMérieux SA (France)

Roche Diagnostics (Switzerland)

Abbott Laboratories (US)

Bruker Corporation (US)

Merck KGaA (Germany)

Agilent Technologies, Inc. (US)

ConvaTec Group plc (UK)

Cepheid (US)

HiMedia Laboratories Pvt. Ltd. (India)

Liofilchem s.r.l. (Italy)

Accelerate Diagnostics, Inc. (US)

Creative Diagnostics (US)

Bio-Rad Laboratories (US)

Synbiosis (UK)

ELITechGroup (France)

QIAGEN N.V. (Germany)

FAQs

Antimicrobial Susceptibility Testing Market size was valued at USD 4.63 Billion in 2024 and is poised to grow from USD 4.87 Billion in 2025 to USD 7.31 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026–2033).

The competitive landscape of the antimicrobial susceptibility testing industry presents a combination of a plethora of market players, engaged in offering effective technologies and products. The leading market players like Becton, Dickinson and Company (BD), Thermo Fisher Scientific, Siemens Healthineers, and bioMérieux are focused on offering integrated solutions, innovative diagnostic technologies, and improved microbiology systems. Companies are also investing in R&D to develop improved testing methods and strategic alliances to expand market reach. Overall, the antimicrobial susceptibility testing market market is differentiated by collaborations, innovations, and focus on addressing the obstacles. 'Thermo Fisher Scientific Inc. (US)', 'Bio-Rad Laboratories, Inc. (US) ', 'Danaher Corporation (US) ', 'Becton, Dickinson and Company (US) ', 'bioMerieux SA (France) ', 'Roche Diagnostics (Switzerland) ', 'Abbott Laboratories (US) ', 'Bruker Corporation (US) ', 'Merck KGaA (Germany) ', 'Agilent Technologies, Inc. (US) ', 'ConvaTec Group plc (UK) ', 'HiMedia Laboratories Pvt. Ltd. (India) ', 'Liofilchem s.r.l. (Italy) ', 'Accelerate Diagnostics, Inc. (US) ', 'Creative Diagnostics (US) ', 'Bio-Rad Laboratories (US) ', 'Synbiosis (UK) ', 'QIAGEN N.V. (Germany)'

The growth of AMR is a major threat to global health. Health organizations and authorities are focusing on the need for efficient AST to observe resistance patterns. This helps in the guidance of treatment decisions and encouraging the use of antibiotics. Also, growing cases of infectious diseases are supported by factors like travel, urbanization, and population growth that demand treatment and diagnosis. This drives the demand for effective and reliable AST.

Growing Adoption of Rapid Testing Techniques: There is a rising focus on rapid antimicrobial susceptibility testing that offers immediate results, mostly within a few hours instead of days. Methods like mass spectrometry, molecular diagnostics, and automated systems are currently being developed to accelerate the detection of pathogens and susceptibility profiles. This is especially useful in critical care settings, wherein prompt decisions are important, affecting patient outcomes.

Geographically, North America dominated the AST market in the previous years and is expected to lead over the forecast period owing to the developed healthcare infrastructure, strong research and development, and rising cases of infectious diseases. The region holds high-tech healthcare systems with superior diagnostic facilities and laboratories, allowing widespread adoption of antimicrobial susceptibility testing. There is a robust investment in research and development from private and public firms that nurture advancements and innovations in AST methods and technologies. The region also faces a large population with infectious diseases, thus impacting regional growth. The key players profiled in the region include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Abbott Laboratories, Agilent Technologies, Inc., and more.

Antimicrobial Susceptibility Testing Market

Report ID: SQMIG35B2120

Top Antimicrobial Susceptibility Testing Companies

Antimicrobial Susceptibility Testing Market Competitive Landscape

FAQs

Request Free Customization

Top Antimicrobial Susceptibility Testing Companies

Antimicrobial Susceptibility Testing Market Competitive Landscape

FAQs

What is the global market size of Antimicrobial Susceptibility Testing Market?

Who are the key vendors in the Antimicrobial Susceptibility Testing Market?

What is the key driver of Antimicrobial Susceptibility Testing Market?

What is the key market trend for Antimicrobial Susceptibility Testing Market?

Which region accounted for the largest share in Antimicrobial Susceptibility Testing Market?

Request Free Customization